Clinical Trials Logo

E. Coli Infection clinical trials

View clinical trials related to E. Coli Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04574596 Completed - E Coli Infection Clinical Trials

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

SHREC
Start date: November 12, 2020
Phase:
Study type: Observational

This is a prospective, observational, multicenter, case-control study.

NCT ID: NCT04117113 Completed - E. Coli Infection Clinical Trials

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)

EXPECT-2
Start date: October 22, 2019
Phase:
Study type: Observational

The purpose of this study is to collect information from study participants who are hospitalized with an invasive disease caused by Extraintestinal pathogenic E. coli (ExPEC). This information will be used to support the development of a new vaccine to prevent Extraintestinal pathogenic Escherichia coli (ExPEC). E. coli bacteria are a leading cause of serious infections. Especially adults older than 60 years have a higher risk of developing such infections. To date, there is no vaccine available to prevent E. coli infections. To support the development of a vaccine, more information about E. coli infections is first needed. This information will be collected in the current study, such as: - Medical information such as medical history, diagnosis, duration of hospitalization - Treatment and outcome of the Extraintestinal pathogenic Escherichia coli (ExPEC) - Laboratory information

NCT ID: NCT00298103 Completed - E Coli Infection Clinical Trials

Antibiotic Resistant Community-Acquired E. Coli

Start date: February 2006
Phase: N/A
Study type: Observational

The purpose of this study is to review patients with E. coli infections at UPMC from January 1, 2004 to December 31, 2005 to determine if these infections have arisen in the community rather than in hospitals or nursing homes. The occurrence of such resistant isolates could be devastating if they were associated with bloodstream infection, such as sometimes accompanies urinary tract infection, since antibiotic resistant E. coli is not suspected in isolates coming from the community.